FPAS
PBYI icon

Focus Partners Advisor Solutions’s Puma Biotechnology PBYI Stock Holding History

Focus Partners Advisor Solutions’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-19,235
Closed -$49K – 850
2024
Q3 		$49K Buy
19,235
+15
+0.1% +$45 ﹤0.01% 743
2024
Q2 		$62.7K Hold
19,220
– – ﹤0.01% 630
2024
Q1 		$102K Hold
19,220
– – ﹤0.01% 595
2023
Q4 		$83.2K Hold
19,220
– – ﹤0.01% 407
2023
Q3 		$50.5K Hold
19,220
– – ﹤0.01% 435
2023
Q2 		$67.8K Hold
19,220
– – ﹤0.01% 371
2023
Q1 		$59.4K Hold
19,220
– – ﹤0.01% 350
2022
Q4 		$81.3K Hold
19,220
– – 0.01% 329
2022
Q3 		$46K Hold
19,220
– – ﹤0.01% 396
2022
Q2 		$55K Buy
+19,220
New +$47.8K ﹤0.01% 352

Other funds holding PBYI

ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Focus Partners Advisor Solutions's PBYI Position: Q4 2024 in Review

Focus Partners Advisor Solutions sold out of Puma Biotechnology (PBYI) in Q4 2024, closing a stake of 19,235 shares — an estimated $49K sold.

Focus Partners Advisor Solutions first reported a position in PBYI in Q2 2022 and held it in 10 quarters. The position peaked at $102K in Q1 2024. 112 funds tracked by Wall St. Rank hold PBYI as of Q4 2024.

  • Focus Partners Advisor Solutions reported no remaining Puma Biotechnology position as of Q4 2024 after selling out during the quarter.
  • Focus Partners Advisor Solutions sold 19,235 Puma Biotechnology shares in Q4 2024, an estimated $49K.
  • Focus Partners Advisor Solutions first reported a position in Puma Biotechnology in Q2 2022 and held it in 10 quarters.
  • Focus Partners Advisor Solutions's Puma Biotechnology position peaked at $102K in Q1 2024.
  • 112 funds tracked by Wall St. Rank held Puma Biotechnology as of Q4 2024.

Based on Focus Partners Advisor Solutions's 13F filing for Q4 2024, filed 18 Feb 2025.